| Vision Source Owasso | |
|
8430 N 123rd East Ave, Owasso, OK 74055-2130 | |
| (918) 272-5755 | |
| (918) 272-0330 |
| Full Name | Vision Source Owasso |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 8430 N 123rd East Ave, Owasso, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497168587 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2137 (Oklahoma) | Primary |
| Provider Name | Michael William Gaydos |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1225301443 PECOS PAC ID: 7113144098 Enrollment ID: I20141018000159 |
News Archive
University of Utah Department of Medicine researchers have received $16 million from the National Institutes of Health (NIH) to set up a translational research center to study the cellular and molecular causes of blood clots, a serious threat to millions of people who have diabetes, are obese or have other metabolic disorders.
The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.
Understanding the structure of proteins is a vital first step in developing new drugs, but to date, researchers have had difficulty studying the large number of proteins that are normally embedded in the cell membrane, a family of proteins that includes those involved in cancer-related signaling processes.
Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.
› Verified 6 days ago
| Provider Name | Caitlin B Chevalier |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1548747272 PECOS PAC ID: 1456602002 Enrollment ID: I20181016000323 |
News Archive
University of Utah Department of Medicine researchers have received $16 million from the National Institutes of Health (NIH) to set up a translational research center to study the cellular and molecular causes of blood clots, a serious threat to millions of people who have diabetes, are obese or have other metabolic disorders.
The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.
Understanding the structure of proteins is a vital first step in developing new drugs, but to date, researchers have had difficulty studying the large number of proteins that are normally embedded in the cell membrane, a family of proteins that includes those involved in cancer-related signaling processes.
Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.
› Verified 6 days ago
| Provider Name | Judson Cash Chevalier |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1104303783 PECOS PAC ID: 2567799596 Enrollment ID: I20190813002880 |
News Archive
University of Utah Department of Medicine researchers have received $16 million from the National Institutes of Health (NIH) to set up a translational research center to study the cellular and molecular causes of blood clots, a serious threat to millions of people who have diabetes, are obese or have other metabolic disorders.
The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.
Understanding the structure of proteins is a vital first step in developing new drugs, but to date, researchers have had difficulty studying the large number of proteins that are normally embedded in the cell membrane, a family of proteins that includes those involved in cancer-related signaling processes.
Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vision Source Owasso 8430 N 123rd East Ave, Owasso, OK 74055-2130 Ph: (918) 272-5755 | Vision Source Owasso 8430 N 123rd East Ave, Owasso, OK 74055-2130 Ph: (918) 272-5755 |
News Archive
University of Utah Department of Medicine researchers have received $16 million from the National Institutes of Health (NIH) to set up a translational research center to study the cellular and molecular causes of blood clots, a serious threat to millions of people who have diabetes, are obese or have other metabolic disorders.
The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.
Understanding the structure of proteins is a vital first step in developing new drugs, but to date, researchers have had difficulty studying the large number of proteins that are normally embedded in the cell membrane, a family of proteins that includes those involved in cancer-related signaling processes.
Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.
› Verified 6 days ago
Chad J Edwards, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12455 E 100th St N # 110, Owasso, OK 74055 Phone: 918-274-7100 Fax: 918-584-4479 | |
Mr. Robert Rendell Vincent, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12406 E 86th St N, Owasso, OK 74055 Phone: 918-376-2700 Fax: 918-376-2722 | |
Drs. Hinkle & Cash Opt,, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12720 E 86th St N, Owasso, OK 74055 Phone: 918-272-5311 | |
Jan Jay Rigney O.d. Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 11880 E 86th St N, Owasso, OK 74055 Phone: 918-272-3937 Fax: 918-272-4251 | |
Dr. Jennifer Lynn Reynolds, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12711 E 86th Pl N Ste 102, Owasso, OK 74055 Phone: 918-376-4100 Fax: 888-299-4619 | |
Lanita R Thomas, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12406 E 86th St N, Owasso, OK 74055 Phone: 918-376-2700 Fax: 918-376-2722 |